News & Commentary on Prescription Drug & Medical Device Lawsuits
Two articles popped up in my inbox today. The first tells the sad story of a man who died after taking a supplement known as “Stiff Nights.”
“A Kansas City man died last year after taking an unapproved erectile dysfunction drug allegedly labeled as a dietary supplement, a Jackson County lawsuit says.
David R.
…
A recent international online pharmacy crackdown has led to over $41 million in illegal drugs confiscated. These counterfeit drugs were part of a wave of over 1,600 websites that were shut down during the series of busts conducted by U.S. and international regulators. The U.S. Food and Drug Administration (FDA) claimed that it used…
Published in a 2005 edition of the Journal of the American Medical Association, a study by Dr. Eydie L. Moses-Kolko et al., titled “Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors,” reviews the danger posed to infants whose mothers used serotonin reuptake inhibitors (SRIs), a new type of antidepressant and…
A 2006 study from Denmark, published in the medical journal Epidemiology, has evaluated the risk for birth defects and other neonatal complications that results from maternal use of SSRI drugs during pregnancy. “SSRI” stands for selective serotonin reuptake inhibitor and represents a new class of antidepressant drugs that change levels of serotonin in the…
Spina Bifida (“myelomeningocele” being the most common form) is a birth defect in the larger class of “neural tube defects,” characterized by the malformation or underdevelopment of the neural tube in a developing infant before birth. In spina bifida, “the backbone and spinal canal do not close before birth”[1] as they normally would.
PubMed…
Anal atresia, or “imperforate anus,” is a congenital birth defect “in which the opening to the anus is missing or blocked.”[1] PubMed Health, a prominent online medical encyclopedia curated by the U.S. National Library of Medicine, states that anal atresia may manifest in several different ways:
…
A recent study published in the British Journal of Medicine has investigated the connection between maternal use of selective serotonin reuptake inhibitor drugs (SSRIs) such as Zoloft®, Paxil®, Prozac®, Celexa®, and Lexapro® during pregnancy and the development of persistent pulmonary hypertension in the newborn. This study, published by Helle Kieler et al. corroborates earlier research…
A study published in 2002 in the American Journal of Psychiatry by Dr. Gregory E. Simon, et al. goes great lengths to elucidate the danger of maternal use of antidepressant drugs during pregnancy. In this study, Simon gathered data from the Group Health Corporation, “a prepaid health plan serving approximately 400,000 members in Washington…
A recent study published in the Archives of General Psychiatry set out to determine whether it was worse for a developing fetus to be exposed to antidepressant drugs during gestation or to be carried to term by a mother-to-be who suffered from depression during pregnancy. This study, published by Dr. Tim F. Oberlander et al.…
In 2010, a Danish study published in the medical journal Clinical Epidemiology set out to evaluate the danger posed to infants born to mothers who used selective serotonin reuptake inhibitors (SSRIs, a new class of antidepressant drugs including Zoloft®, Paxil®, and Prozac®) during early pregnancy.
The study, published by Jette B. Kornum et al.…